规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
50mg | ¥ ȏǪDžȰIJIJ | 7 | > 10 | 5 | 7 | ¥ ŻDžŻȰIJIJ | - + | ||
100mg | ¥ ȻƤDžȰIJIJ | 7 | 4 | > 10 | 6 | ¥ ǷIJDžȰIJIJ | - + | ||
250mg | ¥ ƤŻǪƤȰIJIJ | > 10 | 4 | > 10 | 6 | ¥ ƤIJŻƹȰIJIJ | - + | ||
1g | ¥ ƹȻƹDžȰIJIJ | > 10 | 7 | 5 | > 10 | ¥ ƈDžȻŻȰIJIJ | - + | ||
5g | ¥ ƤȏŻIJȏȰIJIJ | 2 | 3 | 8 | 8 | ¥ ƤDžȏȻǷȰIJIJ | - + | ||
10g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
25g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
100g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
产品编号
1394355
CAS 号
3086-91-7
中文名称
2-氨基-4-氯-5-氨磺酰苯甲酸
MDL 号
MFCD03423689
分子量
250.66
存储条件
2-8°C, protect from light
网页展示纯度为入库指导纯度值,各批次间存在一定差异,实际纯度以收货为准
熔点
268-271 °C
沸点
549.2±60.0 °C at 760 mmHg
闪点
旋光
描述
TPSA
123.48
LogP
0.2678
H_Acceptors
4
H_Donors
3
Rotatable_Bonds
2
[1]. B Wesley-Hadzija, et al. Thin-layer chromatographic determination of furosemide and 4-chloro-5-sulfamoyl anthranilic acid in plasma and urine. J Chromatogr. 1982 May 14;229(2):425-32.
[2]. D E Smith, et al. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay. Drug Metab Dispos. 1980 Sep-Oct;8(5):337-42.
[3]. F Andreasen, et al. The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon. Acta Pharmacol Toxicol (Copenh). 1980 Sep;47(3):202-7.
[4]. F Andreasen, et al. The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products. Acta Pharmacol Toxicol (Copenh). 1981 Sep;49(3):223-9.
[5]. G M Hanna, et al. Stability-indicating proton nuclear magnetic resonance spectroscopic assay method for furosemide in tablets and injections. J AOAC Int. 1993 May-Jun;76(3):526-30.
警示图
警示词
Warning
危险申明
H411
警告申明
P273-P391-P501
GHS 编码
GHS09
危险类别
9
UN 编码
3077
包装等级
Ⅲ
展开更多
现货供应
专业护航
售后无忧
品质保障
无需凑单